Skip to Main Content

Author Details

Yong Jae Shin
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
2001
46
27
PMIDPaper TitleJournal TitlePublished Year
36972629Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5.Neoplasia2023
32120790Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening.Cancers (Basel)2020
32070411Comprehensive pharmacogenomic characterization of gastric cancer.Genome Med2020
33044225Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.J Clin Invest2020
32870163Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.J Clin Invest2020
29786075TP53 gain-of-function mutation promotes inflammation in glioblastoma.Cell Death Differ2019
31836706Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy.Nat Commun2019
29939324Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.Neuro Oncol2019
30898893PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma.J Exp Med2019
30804471Ly6G<sup>+</sup> inflammatory cells enable the conversion of cancer cells to cancer stem cells in an irradiated glioblastoma model.Cell Death Differ2019
30759398Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.Cell Rep2019
29129044Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.Cancer Res Treat2018
29937354Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors.Cancer Cell2018
30262818Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.Nat Genet2018
29715102Pharmacokinetics, Biodistribution, and Toxicity Evaluation of Anti-SEMA3A (F11) in <i>In Vivo</i> Models.Anticancer Res2018
29535421Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.Oncogene2018
28737508Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.J Clin Invest2017
28263318Spatiotemporal genomic architecture informs precision oncology in glioblastoma.Nat Genet2017
26032834USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance.Neuro Oncol2016
27270107Clonal evolution of glioblastoma under therapy.Nat Genet2016
26023737In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma.Oncotarget2015
26160174The Role of the Pleckstrin Homology Domain-containing Protein CKIP-1 in Activation of p21-activated Kinase 1 (PAK1).J Biol Chem2015
23357239Construction of yeast strains useful for screening drugs that inhibit glucose uptake and glycolysis.Anal Biochem2013
23885116Protein kinase CK2 phosphorylates and activates p21-activated kinase 1.Mol Biol Cell2013
23936510Evidence for a novel mechanism of the PAK1 interaction with the Rho-GTPases Cdc42 and Rac.PLoS One2013
23684459Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells.Cancer Cell2013
23468525Mth1 regulates the interaction between the Rgt1 repressor and the Ssn6-Tup1 corepressor complex by modulating PKA-dependent phosphorylation of Rgt1.Mol Biol Cell2013
22272343The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.PLoS One2012
22958823JNK3 perpetuates metabolic stress induced by Aβ peptides.Neuron2012
20045939Zeolite 4A, a synthetic silicate, suppresses melanogenesis through the degradation of microphthalmia-associated transcription factor by extracellular signal-regulated kinase activation in B16F10 melanoma cells.Biol Pharm Bull2010
19218870Epidermal growth factor receptor is involved in clusterin-induced astrocyte proliferation.Neuroreport2009
19886038Simvastatin acts as an inhibitor of interferon gamma-induced cycloxygenase-2 expression in human THP-1 cells, but not in murine RAW264.7 cells.Biocell2009
195462542,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces calcium influx through T-type calcium channel and enhances lysosomal exocytosis and insulin secretion in INS-1 cells.Int J Toxicol2009
18021740Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras.Biochem Biophys Res Commun2008
19018768Curcumin attenuates cytochrome P450 induction in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin by ROS-dependently degrading AhR and ARNT.Cancer Sci2008
18985009LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression.Exp Mol Med2008
18985005STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination.Exp Mol Med2008
18625301Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT signaling in activated microglia.Free Radic Biol Med2008
18414006Arginine deiminase enhances MCF-7 cell radiosensitivity by inducing changes in the expression of cell cycle-related proteins.Mol Cells2008
16411126Clusterin induces differentiation of pancreatic duct cells into insulin-secreting cells.Diabetologia2006
17179861Clusterin enhances proliferation of primary astrocytes through extracellular signal-regulated kinase activation.Neuroreport2006
16038898Clusterin interacts with SCLIP (SCG10-like protein) and promotes neurite outgrowth of PC12 cells.Exp Cell Res2005
15382078Arginine deiminase enhances dexamethasone-induced cytotoxicity in human T-lymphoblastic leukemia CCRF-CEM cells.Int J Cancer2004
12942125Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth.Br J Cancer2003
11911465Characterization of mycoplasma arginine deiminase expressed in E. coli and its inhibitory regulation of nitric oxide synthesis.Mol Cells2002
11793021Clusterin expression during regeneration of pancreatic islet cells in streptozotocin-induced diabetic rats.Diabetologia2001
  • 1 - 46 of 46

Recommended Authors

university of california san diego Department of Pediatrics, University of California
Career Start Year 2007
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 2005
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC)
Career Start Year 2004
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 2003
Number of shared co-authors 3
School of Medicine and Pharmacy, Ocean University of China
Career Start Year 2003
Number of shared co-authors 3
Southern Medical University
Career Start Year 2002
Number of shared co-authors 2
Institute of Anatomy, Technische Universitat Dresden School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 11
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Mossakowski Medical Research Institute, Polish Academy of Sciences
Career Start Year 1999
Number of shared co-authors 3
VTT Technical Research Centre of Finland Ltd
Career Start Year 1999
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Guizhou Medical University
Career Start Year 1997
Number of shared co-authors 1
The Institute of Biomedical Sciences, East China Normal University
Career Start Year 1994
Number of shared co-authors 0
Northwestern University
Career Start Year 1992
Number of shared co-authors 3
Georgetown University Medical Center
Career Start Year 1991
Number of shared co-authors 0
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Career Start Year 1990
Number of shared co-authors 5
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
University of California San Diego
Career Start Year 1988
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 5
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 0
Moores Cancer Center, University of California San Diego
Career Start Year 1984
Number of shared co-authors 0
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 0
Atrium Health-Levine Cancer Institute
Career Start Year 1979
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 5

Collaborators

Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 22
Korea University, College of Medicine
Co-authored papers 10
Seoul National University, College of Medicine
Co-authored papers 9
Touro College of Osteopathic Medicine
Co-authored papers 8
Lerner Research Institute, Cleveland Clinic
Co-authored papers 7
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 6
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 5
Sungkyunkwan University
Co-authored papers 5
University of Alabama at Birmingham
Co-authored papers 5
Inha University
Co-authored papers 5
Korea University College of Medicine
Co-authored papers 4
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 4
University of Chinese Academy of Sciences
Co-authored papers 3
Columbia University Vagelos College of Physicians and Surgeons
Co-authored papers 3
Research Institute for Future Medicine, Samsung Medical Center
Co-authored papers 3
Children's Hospital Boston
Co-authored papers 3
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 3
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 3
The Hong Kong University of Science and Technology
Co-authored papers 3
Genomic Medicine Institute, Medical Research Center, Seoul National University
Co-authored papers 3
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 3
Merck & Co. Inc.
Co-authored papers 3
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 3
Co-authored papers 3
Gangnam Severance Hospital
Co-authored papers 3
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Columbia University
Co-authored papers 2
Sungkyunkwan University
Co-authored papers 2
Samsung Medical Center, Sungkyunkwan University
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2